Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Masahiko Sato
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Living Beings
Concepts & Ideas
Chemicals & Drugs
Anatomy
Phenomena
Physiology
Sign-in to see full Profile
Network (preview)
23
Bryant, Henry
13
Ma, Yanfei
11
Westmore, Michael
7
Turner, Charles
7
Dodge, Jeffrey
7
Frolik, Charles
7
Glasebrook, Andrew
6
Geiser, Andrew
6
Adrian, Mary
6
Vahle, John
5
Short, LL
5
Yang, NN
5
Zeng, Qingqiang
5
Burr, David
5
Cain, Ricky
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Masahiko Sato (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Vahle John L; Zuehlke Ulrich; Schmidt Allen; Westmore Michael; Chen Peiqi; Sato Masahiko
Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)].
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(12):2033-9.
-
2007: Han Bomie; Copeland Marci; Geiser Andrew G; Hale Laura V; Harvey Anita; Ma Yanfei L; Powers Connie S; Sato Masahiko; You Jinsam; Hale John E
Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity.
Journal of proteome research 2007;6(11):4218-29.
-
2007: Stepan Jan J; Burr David B; Pavo Imre; Sipos Adrien; Michalska Dana; Li Jiliang; Fahrleitner-Pammer Astrid; Petto Helmut; Westmore Michael; Michalsky David; Sato Masahiko; Dobnig Harald
Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.
Bone 2007;41(3):378-85.
-
2007: Chen Peiqi; Jerome Christopher P; Burr David B; Turner Charles H; Ma Yanfei L; Rana Asad; Sato Masahiko
Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(6):841-8.
-
2007: Hale L V; Galvin R J Sells; Risteli J; Ma Y L; Harvey A K; Yang X; Cain R L; Zeng Q; Frolik C A; Sato M; Schmidt A L; Geiser A G
PINP: a serum biomarker of bone formation in the rat.
Bone 2007;40(4):1103-9.
-
2007: Vahle John L; Sato Masahiko; Long Gerald G
Variations in animal populations over time and differences in diagnostic thresholds used can impact tumor incidence data.
Toxicologic pathology 2007;35(7):1045-6.
-
2006: Allen Matthew R; Iwata Ken; Sato Masahiko; Burr David B
Raloxifene enhances vertebral mechanical properties independent of bone density.
Bone 2006;39(5):1130-5.
-
2006: Allen M R; Follet H; Khurana M; Sato M; Burr D B
Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.
Calcified tissue international 2006;79(4):255-61.
-
2006: Kulkarni Nalini H; Onyia Jude E; Zeng Qingqiang; Tian Xioayan; Liu Min; Halladay David L; Frolik Charles A; Engler Thomas; Wei Tao; Kriauciunas Aidas; Martin T John; Sato Masahiko; Bryant Henry U; Ma Yanfei L
Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(6):910-20.
-
2006: Wallace Owen B; Lauwers Kenneth S; Dodge Jeffrey A; May Scott A; Calvin Joel R; Hinklin Ronald; Bryant Henry U; Shetler Pamela K; Adrian Mary D; Geiser Andrew G; Sato Masahiko; Burris Thomas P
A selective estrogen receptor modulator for the treatment of hot flushes.
Journal of medicinal chemistry 2006;49(3):843-6.
-
2005: Helvering Leah M; Liu Riting; Kulkarni Nalini H; Wei Tao; Chen Peining; Huang Shuguang; Lawrence Frank; Halladay David L; Miles Rebecca R; Ambrose Emily M; Sato Masahiko; Ma Yanfei L; Frolik Charles A; Dow Ernst R; Bryant Henry U; Onyia Jude E
Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene.
Molecular pharmacology 2005;68(5):1225-38.
-
2005: Geiser Andrew G; Hummel Conrad W; Draper Michael W; Henck Judith W; Cohen Ilene R; Rudmann Daniel G; Donnelly Kevin B; Adrian Mary D; Shepherd Timothy A; Wallace Owen B; McCann Denis J; Oldham Samuel W; Bryant Henry U; Sato Masahiko; Dodge Jeffrey A
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
Endocrinology 2005;146(10):4524-35.
-
2005: Onyia Jude E; Helvering Leah M; Gelbert Lawrence; Wei Tao; Huang Shuguang; Chen Peining; Dow Ernst R; Maran Avudaiappan; Zhang Minzhi; Lotinun Sutada; Lin Xi; Halladay David L; Miles Rebecca R; Kulkarni Nalini H; Ambrose Emily M; Ma Yanfei L; Frolik Charles A; Sato Masahiko; Bryant Henry U; Turner Russell T
Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray.
Journal of cellular biochemistry 2005;95(2):403-18.
-
2005: Alkhiary Yaser M; Gerstenfeld Louis C; Krall Elizabeth; Westmore Michael; Sato Masahiko; Mitlak Bruce H; Einhorn Thomas A
Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34).
The Journal of bone and joint surgery. American volume 2005;87(4):731-41.
-
2005: Helvering L M; Adrian M D; Geiser A G; Estrem S T; Wei T; Huang S; Chen P; Dow E R; Calley J N; Dodge J A; Grese T A; Jones S A; Halladay D L; Miles R R; Onyia J E; Ma Y L; Sato M; Bryant H U
Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus.
Biology of reproduction 2005;72(4):830-41.
-
2005: Ma Yanfei L; Bryant Henry U; Zeng Qingqiang; Schmidt Allen; Jee Webster S S; Sato Masahiko
Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
Journal of bone and mineral metabolism 2005;23 Suppl():62-8.
-
2005: Li Jiliang; Sato Masahiko; Jerome Chris; Turner Charles H; Fan Zaifeng; Burr David B
Microdamage accumulation in the monkey vertebra does not occur when bone turnover is suppressed by 50% or less with estrogen or raloxifene.
Journal of bone and mineral metabolism 2005;23 Suppl():48-54.
-
2004: Vahle John L; Long Gerald G; Sandusky George; Westmore Michael; Ma Yanfei Linda; Sato Masahiko
Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose.
Toxicologic pathology 2004;32(4):426-38.
-
2004: Sato Masahiko; Westmore Michael; Ma Yanfei L; Schmidt Allen; Zeng Qing Q; Glass Emmett V; Vahle John; Brommage Robert; Jerome Christopher P; Turner Charles H
Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(4):623-9.
-
2003: Alvarez Enrique; Westmore Michael; Galvin Rachelle J Sells; Clapp Crystal L; Considine Eileen L; Smith Shawn J; Keyes Kristan; Iversen Philip W; Delafuente Dawn M; Sulaimon Shola; Zambrano Carmen; Ma Linda; Sato Masahiko; Martin T John; Teicher Beverly A; Galbreath Elizabeth J
Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5705-13.
-
2003: Frolik Charles A; Black Elwood C; Cain Ricky L; Satterwhite Julie H; Brown-Augsburger Patricia L; Sato Masahiko; Hock Janet M
Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure.
Bone 2003;33(3):372-9.
-
2003: Ma Yanfei L; Bryant Henry U; Zeng Qingqiang; Schmidt Allen; Hoover Jennifer; Cole Harlan W; Yao Wei; Jee Webster S S; Sato Masahiko
New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Endocrinology 2003;144(5):2008-15.
-
2002: Ma Yanfei L; Bryant Henry U; Zeng Qingqiang; Palkowitz Alan; Jee Webster S S; Turner Charles H; Sato Masahiko
Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(12):2256-64.
-
2002: Cao Yongping; Mori Satoshi; Mashiba Tasuku; Westmore Michael S; Ma Linda; Sato Masahiko; Akiyama Tomoyuki; Shi Liping; Komatsubara Satoshi; Miyamoto Kensaku; Norimatsu Hiromichi
Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(12):2237-46.
-
2002: Sato M; Vahle J; Schmidt A; Westmore M; Smith S; Rowley E; Ma L Y
Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH.
Endocrinology 2002;143(9):3230-42.
-
2002: Sato Masahiko; Ma Y L; Hock J M; Westmore M S; Vahle J; Villanueva A; Turner C H
Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment.
The Journal of pharmacology and experimental therapeutics 2002;302(1):304-13.
-
2002: Vahle John L; Sato Masahiko; Long Gerald G; Young Jamie K; Francis Paul C; Engelhardt Jeffery A; Westmore Michael S; Linda Yanfei; Nold James B
Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.
Toxicologic pathology 2002;30(3):312-21.
-
2001: Mashiba T; Burr D B; Turner C H; Sato M; Cain R L; Hock J M
Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits.
Bone 2001;28(5):538-47.
-
2001: Kaiser E; Sato M; Onyia J E; Chandrasekhar S
Parathyroid hormone (1-34) regulates integrin expression in vivo in rat osteoblasts.
Journal of cellular biochemistry 2001;83(4):617-30.
-
2000: Sato M; Westmore M; Clendenon J; Smith S; Hannum B; Zeng G Q; Brommage R; Turner C H
Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2000;11(10):871-80.
-
1999: Bryant H U; Glasebrook A L; Yang N N; Sato M
An estrogen receptor basis for raloxifene action in bone.
The Journal of steroid biochemistry and molecular biology 1999;69(1-6):37-44.
-
1999: Hirano T; Burr D B; Turner C H; Sato M; Cain R L; Hock J M
Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(4):536-45.
-
1999: Frolik C A; Cain R L; Sato M; Harvey A K; Chandrasekhar S; Black E C; Tashjian A H; Hock J M
Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(2):163-72.
-
1999: Sato M; Grese T A; Dodge J A; Bryant H U; Turner C H
Emerging therapies for the prevention or treatment of postmenopausal osteoporosis.
Journal of medicinal chemistry 1999;42(1):1-24.
-
1998: Sato M; Zeng G Q; Rowley E; Turner C H
LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
Endocrinology 1998;139(11):4642-51.
-
1998: Sato M; Turner C H; Wang T; Adrian M D; Rowley E; Bryant H U
LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
The Journal of pharmacology and experimental therapeutics 1998;287(1):1-7.
-
1998: Turner R T; Evans G L; Sluka J P; Adrian M D; Bryant H U; Turner C H; Sato M
Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene.
Endocrinology 1998;139(9):3712-20.
-
1998: Geiser A G; Zeng Q Q; Sato M; Helvering L M; Hirano T; Turner C H
Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene.
Bone 1998;23(2):87-93.
-
1998: Grese T A; Pennington L D; Sluka J P; Adrian M D; Cole H W; Fuson T R; Magee D E; Phillips D L; Rowley E R; Shetler P K; Short L L; Venugopalan M; Yang N N; Sato M; Glasebrook A L; Bryant H U
Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.
Journal of medicinal chemistry 1998;41(8):1272-83.
-
1997: Grese T A; Sluka J P; Bryant H U; Cullinan G J; Glasebrook A L; Jones C D; Matsumoto K; Palkowitz A D; Sato M; Termine J D; Winter M A; Yang N N; Dodge J A
Molecular determinants of tissue selectivity in estrogen receptor modulators.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(25):14105-10.
-
1997: Helterbrand J D; Higgs R E; Iversen P W; Tysarczyk-Niemeyer G; Sato M
Application of automatic image segmentation to tibiae and vertebrae from ovariectomized rats.
Bone 1997;21(5):401-9.
-
1997: Sato M; Zeng G Q; Turner C H
Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
Endocrinology 1997;138(10):4330-7.
-
1997: Palkowitz A D; Glasebrook A L; Thrasher K J; Hauser K L; Short L L; Phillips D L; Muehl B S; Sato M; Shetler P K; Cullinan G J; Pell T R; Bryant H U
Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator.
Journal of medicinal chemistry 1997;40(10):1407-16.
-
1997: Dodge J A; Lugar C W; Cho S; Short L L; Sato M; Yang N N; Spangle L A; Martin M J; Phillips D L; Glasebrook A L; Osborne J J; Frolik C A; Bryant H U
Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity.
The Journal of steroid biochemistry and molecular biology 1997;61(1-2):97-106.
-
1996: Dodge J A; Glasebrook A L; Magee D E; Phillips D L; Sato M; Short L L; Bryant H U
Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat.
The Journal of steroid biochemistry and molecular biology 1996;59(2):155-61.
-
1996: Sato M; Rippy M K; Bryant H U
Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1996;10(8):905-12.
-
1996: Yang N N; Bryant H U; Hardikar S; Sato M; Galvin R J; Glasebrook A L; Termine J D
Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.
Endocrinology 1996;137(5):2075-84.
-
1996: Sato M; Bryant H U; Dodge J A; Davis H; Matter W F; Vlahos C J
Effects of wortmannin analogs on bone in vitro and in vivo.
The Journal of pharmacology and experimental therapeutics 1996;277(1):543-50.
-
1995: Sato M; Kim J; Short L L; Slemenda C W; Bryant H U
Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
The Journal of pharmacology and experimental therapeutics 1995;272(3):1252-9.
-
1994: Sato M; McClintock C; Kim J; Turner C H; Bryant H U; Magee D; Slemenda C W
Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994;9(5):715-24.
-
1994: Black L J; Sato M; Rowley E R; Magee D E; Bekele A; Williams D C; Cullinan G J; Bendele R; Kauffman R F; Bensch W R
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
The Journal of clinical investigation 1994;93(1):63-9.
Sign-in to see more
